Group One Trading’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20
Closed -$67 8284
2026
Q1
$81 Sell
20
-9
-31% -$49 ﹤0.01% 7434
2025
Q4
$193 Buy
+29
New +$210 ﹤0.01% 7889
2025
Q1
Sell
-857
Closed -$27.4K 8212
2024
Q4
$40.2K Buy
857
+855
+42,750% +$32.9K ﹤0.01% 5216
2024
Q3
$111 Hold
2
﹤0.01% 6473
2024
Q2
$166 Sell
2
-14
-88% -$1.62K ﹤0.01% 6525
2024
Q1
$2.15K Sell
16
-1
-6% -$143 ﹤0.01% 6473
2023
Q4
$2.64K Hold
17
﹤0.01% 6738
2023
Q3
$3.89K Hold
17
﹤0.01% 6812
2023
Q2
$4.72K Hold
17
﹤0.01% 6744
2023
Q1
$5.93K Sell
17
-4
-19% -$1.5K ﹤0.01% 6205
2022
Q4
$5.8K Sell
21
-100
-83% -$38.4K ﹤0.01% 6274
2022
Q3
$49K Sell
121
-14
-10% -$6.54K ﹤0.01% 5424
2022
Q2
$65K Buy
135
+5
+4% +$2.99K ﹤0.01% 5345
2022
Q1
$103K Buy
130
+90
+225% +$58K ﹤0.01% 5466
2021
Q4
$31K Sell
40
-194
-83% -$165K ﹤0.01% 6704
2021
Q3
$214K Buy
234
+23
+11% +$22.3K ﹤0.01% 5097
2021
Q2
$206K Buy
211
+138
+189% +$127K ﹤0.01% 5224
2021
Q1
$61K Buy
+73
New +$68.1K ﹤0.01% 6081

Other funds holding PPBT

Group One Trading's PPBT Position: Q2 2026 in Review

Group One Trading sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 20 shares — an estimated $67 sold.

Group One Trading first reported a position in PPBT in Q1 2021 and held it in 18 quarters. The position peaked at $214K in Q3 2021. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Group One Trading reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 20 Purple Biotech shares in Q2 2026, an estimated $67.
  • Group One Trading first reported a position in Purple Biotech in Q1 2021 and held it in 18 quarters.
  • Group One Trading's Purple Biotech position peaked at $214K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.